Is Joey Shenzhou Technology Co., Ltd. a listed company?

Beijing Joy Shenzhou Technology Co., Ltd. is a listed company. The company was listed on Shenzhen Stock Exchange on August 6th, 20021with the stock code of 30 1047. Beijing Joy Shenzhou Technology Co., Ltd. is a biotechnology company engaged in the production, sales and technical services of R&D and biochemical reagents.

The company's main business

The main business includes products such as recombinant proteins, antibodies, genes and culture media, as well as services such as development and bioanalysis of recombinant proteins and antibodies, and also provides large-scale pre-clinical production services for pharmaceutical companies or biotechnology companies.

Joy Shenzhou provides high-quality biochemical reagents and high-level technical services for global pharmaceutical R&D enterprises and life science research institutions. The company produces and sells more than 52,000 kinds of off-the-shelf products, including about 6,500 kinds of recombinant proteins, including more than 4,500 kinds of recombinant proteins expressed by human cells, which can fully meet customers' demand for recombinant proteins whose structure and properties are closest to human natural proteins.

The company can also provide about 14000 kinds of antibodies, including about 4900 kinds of monoclonal antibodies, which can cover many fields of life science research and provide "one-stop" biochemical reagent products and related technical services for basic scientific research directions such as molecular biology, cell biology, immunology, developmental biology, stem cell research and innovative drug research and development.

Corporate customer base

Joey Shenzhou's clients include universities, research institutes, R&D pharmaceutical companies and other domestic and foreign biological R&D units. The company has established subsidiaries in the United States, Europe and Japan, accumulated more than 6,000 customers, and continuously improved its brand reputation. Has become one of the leading biochemical reagent technology companies in China. At the same time, it is also an advanced customs certification enterprise with AEO qualification.

Company research results

On February 2, 2002 1 65438, Beijing Joy Shenzhou announced that it had completed a series of work from molecular construction to cell culture, protein purification and quality inspection in just six days, and successfully produced the Omicron mutant RBD protein reagent on June 65438+February1day, which was provided to relevant institutions for research at the first time.

On June 1 day, 2022, Joey Shenzhou announced the successful development of monkeypox-related protein products. According to the published gene sequence of monkeypox virus (West Africa branch), the company successfully developed the recombinant A29 protein expressed by monkeypox A29L gene and the recombinant L 1R protein expressed by L 1R gene.

Honors won by the company

In 2020, Rong won the silver prize in the first medical science and technology innovation competition to fight the epidemic.

In 2020, the category of winners who won the top star award of coronavirus pneumonia-19.

In 20021year, it won the title of "protein supplier worthy of attention in 20021year".

In 2022, it won the highly praised award of "protein suppliers worthy of attention in 2022".

In 2022, it won the title of "successful supplier of research reagents in COVID-19" for two consecutive years.

In 2024, it won the "Growth Factor Supplier Worthy of Attention in 2024" award.